REPLIGEN CORP false 0000730272 0000730272 2021-05-13 2021-05-13

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 13, 2021

 

 

Repligen Corporation

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   000-14656   04-2729386

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

41 Seyon Street, Bldg. 1, Suite 100, Waltham, MA 02453

(Address of Principal Executive Offices) (Zip Code)

(781) 250-0111

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, par value $0.01 per share   RGEN   The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 5.07. Submission of Matters to a Vote of Security Holders.

The 2021 Annual Meeting of Stockholders (the “Annual Meeting”) of Repligen Corporation (the “Company”) was held on May 13, 2021. Proxies were solicited pursuant to the Company’s proxy statement filed on April 21, 2021, and as amended on May 5, 2021, with the Securities and Exchange Commission under Section 14(a) of the Securities Exchange Act of 1934, as amended.

The number of shares of the Company’s common stock, $0.01 par value per share (“Common Stock”), entitled to vote at the Annual Meeting was 54,899,242. The number of shares of Common Stock present or represented by valid proxy at the Annual Meeting was 49,770,243, representing 90.65% of the total number of shares of Common Stock entitled to vote at the Annual Meeting. Each share of Common Stock was entitled to one vote with respect to matters submitted to the Company’s shareholders at the Annual Meeting.

At the Annual Meeting, the Company’s shareholders were asked (i) to elect the Company’s Board of Directors, (ii) to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021, and (iii) to vote to approve, on an advisory basis, the compensation paid to the Company’s named executive officers.

The voting results reported below are final.

Proposal 1 Election of the Board of Directors

Nicolas M. Barthelemy, Karen A. Dawes, Carrie Eglinton Manner, Tony J. Hunt, Rohin Mhatre, Ph.D., Glenn P. Muir, and Thomas F. Ryan, Jr. were duly elected as the Company’s Board of Directors. The results of the election were as follows:

 

NOMINEE    FOR      % FOR     AGAINST      % AGAINST     ABSTAIN      % ABSTAIN     BROKER
NON-
VOTES
 

Nicolas M. Barthelemy

     44,747,544        97.90     931,199        2.04     27,814        0.06     4,063,686  

Karen A. Dawes

     44,853,502        98.13     827,300        1.81     25,755        0.06     4,063,686  

Carrie Eglinton Manner

     45,632,498        99.84     47,910        0.10     26,149        0.06     4,063,686  

Tony J. Hunt

     45,490,558        99.53     188,352        0.41     27,647        0.06     4,063,686  

Rohin Mhatre, Ph.D.

     45,587,563        99.74     91,758        0.20     27,236        0.06     4,063,686  

Glenn P. Muir

     45,275,145        99.06     403,933        0.88     27,479        0.06     4,063,686  

Thomas F. Ryan, Jr

     44,940,652        98.32     739,097        1.62 %     26,808        0.06     4,063,686  

Proposal 2 – Ratify the Appointment of Independent Registered Public Accounting Firm

The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021 was ratified. The results of the ratification were as follows:

 

     FOR     AGAINST     ABSTAIN     BROKER
NON-
VOTES
 

NUMBER

     49,585,459       160,438       24,346    

PERCENTAGE OF VOTED

     99.63     0.32     0.05  


Proposal 3 – Advisory Vote on Compensation of the Named Executive Officers

The compensation paid to the Company’s named executive officers was approved on an advisory basis. The results of the vote were as follows:

 

     FOR     AGAINST     ABSTAIN     BROKER
NON-
VOTES
 

NUMBER

     44,729,097       923,077       54,383       4,063,686  

PERCENTAGE OF VOTED

     97.86     2.02     0.12  


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    REPLIGEN CORPORATION
Date: May 19, 2021     By:  

/s/ Tony J. Hunt

      Tony J. Hunt
      President and Chief Executive Officer
Repligen (NASDAQ:RGEN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Repligen Charts.
Repligen (NASDAQ:RGEN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Repligen Charts.